geometrybase
8a0dfd88f0
Request: - Add extracted PDF text generation to the archivist workflow as a standard step. Changes: - Run PDF text extraction automatically for newly archived HKEX PDF sources. - Make the PDF text extractor incremental and manifest-preserving. - Document extracted-text handling in the archivist skill and README. - Mark generated extracted text as no-diff data evidence. - Backfill extracted text for all archived PDF source references. Verification: - Ran git diff --cached --check. - Ran .venv/bin/python -m py_compile scripts/extract_pdf_text.py scripts/archive_hkex_documents.py. - Ran full PDF extraction, then confirmed an incremental rerun skips unchanged files. - Verified 557 PDF source_refs, 557 manifest rows, all status ok, and zero missing text/hash/path issues. Next useful context: - HKEX HTML notices and Yahoo JSON market data remain under data/raw and are not expected in data/extracted_text.
2254 lines
50 KiB
Plaintext
2254 lines
50 KiB
Plaintext
--- page 1 ---
|
||
CF PharmTech, Inc. / 長風藥業股份有限公司
|
||
ANNOUNCEMENT OF FINAL OFFER PRICE AND
|
||
ALLOTMENT RESULTS
|
||
Unless otherwise defined herein, capitalised terms used in this announcement shall have the same meanings
|
||
as those defined in the prospectus dated September 26, 2025 (the “Prospectus”) issued by CF PharmTech,
|
||
Inc. (長風藥業股份有限公司) (the “Company”).
|
||
SUMMARY
|
||
|
||
Company information
|
||
Stock code 2652
|
||
Stock short name CF PHARMTECH
|
||
Dealings commencement date October 8, 2025*
|
||
*see note at the end of the announcement
|
||
Price Information
|
||
Final Offer Price HK$14.75
|
||
Offer Shares and Share Capital
|
||
Number of Offer Shares 41,198,000 H Shares
|
||
Final Number of Offer Shares in Hong Kong Public
|
||
Offering
|
||
4,120,000 H Shares
|
||
Final Number of Offer Shares in International Offering 37,078,000 H Shares
|
||
Number of issued Shares upon Listing 411,978,387 Shares
|
||
Proceeds
|
||
Gross proceeds (Note) HK$ 607.7 million
|
||
Less: Estimated listing expenses payable based on Offer
|
||
Price
|
||
HK$(82.3) million
|
||
Net proceeds HK$ 525.4 million
|
||
Note:
|
||
|
||
Gross proceeds refers to the amount to which the Company is entitled receive. For details of the use of
|
||
proceeds, please refer to the section headed “Future Plans and Use of Proceeds” of the Prospectus dated
|
||
September 26, 2025.
|
||
|
||
ALLOTMENT RESULTS DETAILS
|
||
HONG KONG PUBLIC OFFERING
|
||
|
||
No. of valid applications 264,209
|
||
No. of successful applications 8,240
|
||
Subscription level 6,697.80 times
|
||
Claw-back triggered N/A
|
||
No. of Offer Shares initially available under the Hong Kong Public
|
||
Offering
|
||
4,120,000 H Shares
|
||
No. of Offer Shares reallocated from the International Offering
|
||
(claw-back)
|
||
N/A
|
||
Final no. of Offer Shares under the Hong Kong Public Offering 4,120,000 H Shares
|
||
% of Offer Shares under the Hong Kong Public Offering to the
|
||
Global Offering
|
||
10.00%
|
||
|
||
|
||
--- page 2 ---
|
||
Note: For details of the final allocation of shares of the H Shares to the Hong Kong Public Offering, investors
|
||
can refer to www.eipo.com.hk/eIPOAllotment to perform a search by identification number or
|
||
www.eipo.com.hk/eIPOAllotment for the full list of allottees.
|
||
INTERNATIONAL OFFERING
|
||
|
||
No. of placees 70
|
||
Subscription Level 12.74 times
|
||
No. of Offer Shares initially available under the International
|
||
Offering
|
||
37,078,000 H Shares
|
||
No. of Offer Shares reallocated to the Hong Kong Public Offering
|
||
(claw-back)
|
||
N/A
|
||
Final no. of Offer Shares under the International Offering 37,078,000 H Shares
|
||
% of Offer Shares under the International Offering to the Global
|
||
Offering
|
||
90.00%
|
||
|
||
The Directors confirm that, to the best of their knowledge, information and belief, save for a consent under
|
||
paragraph 1C(2) of Appendix F1 to the Listing Rules (the “Placing Guidelines”) and Chapter 4.15 of the
|
||
Guide for New Listing Applicants granted by the Stock Exchange to permit the Company to, among other
|
||
things, allocate certain Offer Shares in the International Offering to a close associate of existing Shareholders
|
||
of the Company , (i) none of the Offer Shares subscribed by the placees and the public have been financed
|
||
directly or indirectly by the Company, any of the Directors, Supervisors, chief executive of the Company, Single
|
||
Largest Group of Shareholders, substantial Shareholders, existing Shareholders of the Company or any of its
|
||
subsidiaries or their respective close associates; and (ii) none of the placees and the public who have
|
||
purchased the Offer Shares are accustomed to taking instructions from the Company, any of the Di rectors,
|
||
Supervisors, chief executive of the Company, Single Largest Group of Shareholders, substantial Shareholders,
|
||
existing Shareholders of the Company or any of its subsidiaries or their respective close associates in relation
|
||
to the acquisition, disposal, voting or other disposition of H Shares registered in his/her/its name or otherwise
|
||
held by him/her/it.
|
||
ALLOTEES WITH WAIVERS/CONSENTS OBTAINED
|
||
|
||
Investor
|
||
No. of Offer
|
||
Shares
|
||
allocated
|
||
% of Offer
|
||
Shares
|
||
% of total issued
|
||
H Shares after the
|
||
Global Offering
|
||
% of total
|
||
issued share
|
||
capital after
|
||
the Global
|
||
Offering Relationship
|
||
Allotee with consent under paragraph 1C(2) of the Placing Guidelines and Chapter 4.15 of the Guide for
|
||
New Listing Applicants in relation to subscription for Offer Shares by a close associate of existing
|
||
Shareholders
|
||
Huang Hongbin
|
||
(黃宏彬 ) ( “Mr.
|
||
Huang”)
|
||
813,500 1.97% 0.27% 0.20% A close
|
||
associate of
|
||
existing
|
||
Shareholders
|
||
Allotees with consent under paragraph 1C( 1) of the Placing Guidelines and Chapter 4.15 of the Guide
|
||
for New Listing Applicants in relation to allocations to connected clients Note
|
||
CITIC
|
||
Securities
|
||
International
|
||
Capital
|
||
Management
|
||
5,000 0.0121% 0.0017% 0.0012% A Connected
|
||
Client
|
||
|
||
|
||
--- page 3 ---
|
||
Investor
|
||
No. of Offer
|
||
Shares
|
||
allocated
|
||
% of Offer
|
||
Shares
|
||
% of total issued
|
||
H Shares after the
|
||
Global Offering
|
||
% of total
|
||
issued share
|
||
capital after
|
||
the Global
|
||
Offering Relationship
|
||
Limited
|
||
(“CSICM”)
|
||
China Asset
|
||
Management
|
||
(Hong Kong)
|
||
Limited
|
||
(“China AMC
|
||
HK”)
|
||
5,000 0.0121% 0.0017% 0.0012% A Connected
|
||
Client
|
||
CMBI
|
||
(Singapore) Pte.
|
||
Limited
|
||
(“CMBI SG”)
|
||
10,500 0.0255% 0.0035% 0.0025% A Connected
|
||
Client
|
||
Bosera Asset
|
||
Management
|
||
(International)
|
||
Co., Ltd
|
||
(“Bosera AM”)
|
||
10,500 0.0255% 0.0035% 0.0025% A Connected
|
||
Client
|
||
Note:
|
||
|
||
For details of the consent under paragraph 1C(1) of the Placing Guidelines and Chapter 4.15 of the Guide
|
||
for New Listing Applicants in relation to allocations to connected clients, please refer to the section headed
|
||
“Others/Additional Information – Placing to Connected Clients with a Prior Consent under Paragraph
|
||
1C(1) of the Placing Guidelines” in this announcement.
|
||
|
||
|
||
LOCK-UP UNDERTAKINGS
|
||
Single Largest Group of Shareholders
|
||
Name
|
||
Number of
|
||
Unlisted
|
||
Shares held in
|
||
the Company
|
||
subject to lock-
|
||
up
|
||
undertakings
|
||
upon Listing
|
||
Number of H
|
||
Shares held in
|
||
the Company
|
||
subject to lock-
|
||
up
|
||
undertakings
|
||
upon Listing
|
||
% of total issued
|
||
H Shares after the
|
||
Global Offering
|
||
subject to lock-up
|
||
undertakings
|
||
upon Listing
|
||
% of
|
||
shareholding
|
||
in the
|
||
Company
|
||
subject to
|
||
lock-up
|
||
undertakings
|
||
upon Listing
|
||
Last day
|
||
subject to the
|
||
lock-up
|
||
undertakings
|
||
Note
|
||
Suzhou Pyramid
|
||
Investment
|
||
Management
|
||
Enterprise
|
||
(Limited
|
||
Partnership) / 蘇
|
||
州嶺頭投資管
|
||
理企業(有限合
|
||
夥)
|
||
10,451,618 15,677,427 5.2% 6.3% October 7,
|
||
2026
|
||
Suzhou
|
||
Meizhongrui
|
||
9,585,819 14,378,728 4.8% 5.8% October 7,
|
||
2026
|
||
|
||
|
||
--- page 4 ---
|
||
Name
|
||
Number of
|
||
Unlisted
|
||
Shares held in
|
||
the Company
|
||
subject to lock-
|
||
up
|
||
undertakings
|
||
upon Listing
|
||
Number of H
|
||
Shares held in
|
||
the Company
|
||
subject to lock-
|
||
up
|
||
undertakings
|
||
upon Listing
|
||
% of total issued
|
||
H Shares after the
|
||
Global Offering
|
||
subject to lock-up
|
||
undertakings
|
||
upon Listing
|
||
% of
|
||
shareholding
|
||
in the
|
||
Company
|
||
subject to
|
||
lock-up
|
||
undertakings
|
||
upon Listing
|
||
Last day
|
||
subject to the
|
||
lock-up
|
||
undertakings
|
||
Note
|
||
Investment
|
||
Management
|
||
Enterprise
|
||
(Limited
|
||
Partnership) / 蘇
|
||
州美中瑞投資
|
||
管理企業(有限
|
||
合夥)
|
||
Suzhou Minmei
|
||
Investment
|
||
Management
|
||
Enterprise
|
||
(Limited
|
||
Partnership) / 蘇
|
||
州閩美投資管
|
||
理企業(有限合
|
||
夥)
|
||
8,425,531 12,638,297 4.2% 5.1% October 7,
|
||
2026
|
||
Suzhou
|
||
Yuanchen
|
||
Enterprise
|
||
Management
|
||
Center (Limited
|
||
Partnership) / 蘇
|
||
州遠辰企業管
|
||
理中心(有限合
|
||
夥)
|
||
7,731,913 11,597,869 3.8% 4.7% October 7,
|
||
2026
|
||
Suzhou Wolun
|
||
Enterprise
|
||
Management
|
||
Center (Limited
|
||
Partnership) / 蘇
|
||
州沃倫企業管
|
||
理中心(有限合
|
||
夥)
|
||
4,225,542 6,338,312 2.1% 2.6% October 7,
|
||
2026
|
||
Subtotal 40,420,423 60,630,633 20.1% 24.5%
|
||
Note:
|
||
|
||
The expiry date of the lock -up period shown in the table above is pursuant to the PRC Company Laws. In
|
||
accordance with the relevant Listing Rules/guidance materials, the required lock -up for existing
|
||
Shareholders ends on October 7, 2026, being 12 months following the Listing Date.
|
||
|
||
|
||
--- page 5 ---
|
||
Pre-IPO Investors
|
||
Name
|
||
Number of
|
||
Unlisted
|
||
Shares held in
|
||
the Company
|
||
subject to lock-
|
||
up
|
||
undertakings
|
||
upon Listing
|
||
Number of H
|
||
Shares held in
|
||
the Company
|
||
subject to lock-
|
||
up
|
||
undertakings
|
||
upon Listing
|
||
% of total issued
|
||
H Shares after the
|
||
Global Offering
|
||
subject to lock-up
|
||
undertakings upon
|
||
Listing
|
||
% of
|
||
shareholding
|
||
in the
|
||
Company
|
||
subject to
|
||
lock-up
|
||
undertakings
|
||
upon Listing
|
||
Last day
|
||
subject to the
|
||
lock-up
|
||
undertakings
|
||
Note 11
|
||
Future Industry
|
||
Investment Fund
|
||
(Limited
|
||
Partnership) / 先
|
||
進 製 造 產 業 投
|
||
資基金(有限合
|
||
夥)
|
||
– 26,058,641 8.6% 6.3% October 7,
|
||
2026
|
||
China-
|
||
Singapore
|
||
Suzhou
|
||
Industrial Park
|
||
Venture Co.,
|
||
Ltd. / 中新蘇州
|
||
工 業 園 區 創 業
|
||
投 資 有 限 公 司
|
||
Note 1
|
||
– 12,797,494 4.2% 3.1% October 7,
|
||
2026
|
||
Jiangsu Jiequan
|
||
Oriza
|
||
Intellectual
|
||
Property Science
|
||
and Technology
|
||
Innovation Fund
|
||
(Limited
|
||
Partnership) / 江
|
||
蘇 疌 泉 元 禾 知
|
||
識 產 權 科 創 基
|
||
金( 有限合夥 )
|
||
Note 1
|
||
– 3,614,664 1.2% 0.9% October 7,
|
||
2026
|
||
Shanghai Sihong
|
||
Investment
|
||
Partnership
|
||
(Limited
|
||
Partnership) / 上
|
||
海 思 宏 投 資 合
|
||
夥企業(有限合
|
||
夥 ) (currently
|
||
known as
|
||
Shanghai
|
||
Sihongda
|
||
Enterprise
|
||
15,165,653 – – 3.7% October 7,
|
||
2026
|
||
|
||
|
||
--- page 6 ---
|
||
Name
|
||
Number of
|
||
Unlisted
|
||
Shares held in
|
||
the Company
|
||
subject to lock-
|
||
up
|
||
undertakings
|
||
upon Listing
|
||
Number of H
|
||
Shares held in
|
||
the Company
|
||
subject to lock-
|
||
up
|
||
undertakings
|
||
upon Listing
|
||
% of total issued
|
||
H Shares after the
|
||
Global Offering
|
||
subject to lock-up
|
||
undertakings upon
|
||
Listing
|
||
% of
|
||
shareholding
|
||
in the
|
||
Company
|
||
subject to
|
||
lock-up
|
||
undertakings
|
||
upon Listing
|
||
Last day
|
||
subject to the
|
||
lock-up
|
||
undertakings
|
||
Note 11
|
||
Management
|
||
Consulting
|
||
Partnership
|
||
(Limited
|
||
Partnership) ( 上
|
||
海 思 宏 達 企 業
|
||
管 理 諮 詢 合 夥
|
||
企業 ( 有 限 合
|
||
夥)))
|
||
Beijing SL
|
||
Pharmaceutical
|
||
Co., Ltd. / 北京
|
||
雙 鷺 藥 業 股 份
|
||
有限公司
|
||
10,615,653 4,550,000 1.5% 3.7% October 7,
|
||
2026
|
||
Jiangsu CMB
|
||
Modern Industry
|
||
Equity
|
||
Investment Fund
|
||
Phase I (Limited
|
||
Partnership) / 江
|
||
蘇 招 銀 現 代 產
|
||
業 股 權 投 資 基
|
||
金一期(有限合
|
||
夥) Note 2
|
||
13,545,187 – – 3.3% October 7,
|
||
2026
|
||
Nanjing CMB
|
||
Gongying
|
||
Equity
|
||
Investment
|
||
Partnership
|
||
Enterprise
|
||
(Limited
|
||
Partnership) / 南
|
||
京 市 招 銀 共 贏
|
||
股 權 投 資 合 夥
|
||
企業 ( 有 限 合
|
||
夥) Note 2
|
||
120,490 – – 0.0%* October 7,
|
||
2026
|
||
Shanghai Lianyi
|
||
Investment
|
||
Center (Limited
|
||
Partnership) / 上
|
||
海 聯 一 投 資 中
|
||
心(有限合夥)
|
||
– 12,048,878 4.0% 2.9% October 7,
|
||
2026
|
||
|
||
|
||
--- page 7 ---
|
||
Name
|
||
Number of
|
||
Unlisted
|
||
Shares held in
|
||
the Company
|
||
subject to lock-
|
||
up
|
||
undertakings
|
||
upon Listing
|
||
Number of H
|
||
Shares held in
|
||
the Company
|
||
subject to lock-
|
||
up
|
||
undertakings
|
||
upon Listing
|
||
% of total issued
|
||
H Shares after the
|
||
Global Offering
|
||
subject to lock-up
|
||
undertakings upon
|
||
Listing
|
||
% of
|
||
shareholding
|
||
in the
|
||
Company
|
||
subject to
|
||
lock-up
|
||
undertakings
|
||
upon Listing
|
||
Last day
|
||
subject to the
|
||
lock-up
|
||
undertakings
|
||
Note 11
|
||
Shenzhen GTJA
|
||
Ruipeng
|
||
Investment
|
||
Partnership
|
||
(Limited
|
||
Partnership) / 深
|
||
圳 市 高 特 佳 睿
|
||
鵬 投 資 合 夥 企
|
||
業( 有限合夥 )
|
||
Note 3
|
||
– 6,024,439 2.0% 1.5% October 7,
|
||
2026
|
||
Jiangsu Jiequan
|
||
GTJA Medical
|
||
Industry
|
||
Investment Fund
|
||
(Limited
|
||
Partnership) / 江
|
||
蘇 疌 泉 高 特 佳
|
||
醫 療 產 業 投 資
|
||
基金 ( 有 限 合
|
||
夥) Note 3
|
||
– 5,470,464 1.8% 1.3% October 7,
|
||
2026
|
||
CICC
|
||
Generation
|
||
(Suzhou)
|
||
Emerging
|
||
Industry Equity
|
||
Investment Fund
|
||
Partnership
|
||
(Limited
|
||
Partnership) / 中
|
||
金啟辰 ( 蘇州 )
|
||
新 興 產 業 股 權
|
||
投資 基金合夥
|
||
企業 ( 有 限 合
|
||
夥)
|
||
3,401,474 7,936,774 2.6% 2.8% October 7,
|
||
2026
|
||
Suzhou Meimin
|
||
Enterprise
|
||
Management
|
||
Center (Limited
|
||
Partnership) / 蘇
|
||
州 美 閩 企 業 管
|
||
理中心(有限合
|
||
夥)
|
||
4,316,560 6,474,841 2.1% 2.6% October 7,
|
||
2026
|
||
|
||
|
||
--- page 8 ---
|
||
Name
|
||
Number of
|
||
Unlisted
|
||
Shares held in
|
||
the Company
|
||
subject to lock-
|
||
up
|
||
undertakings
|
||
upon Listing
|
||
Number of H
|
||
Shares held in
|
||
the Company
|
||
subject to lock-
|
||
up
|
||
undertakings
|
||
upon Listing
|
||
% of total issued
|
||
H Shares after the
|
||
Global Offering
|
||
subject to lock-up
|
||
undertakings upon
|
||
Listing
|
||
% of
|
||
shareholding
|
||
in the
|
||
Company
|
||
subject to
|
||
lock-up
|
||
undertakings
|
||
upon Listing
|
||
Last day
|
||
subject to the
|
||
lock-up
|
||
undertakings
|
||
Note 11
|
||
Shanghai
|
||
Jinshahe Equity
|
||
Investment
|
||
Enterprise
|
||
(Limited
|
||
Partnership) / 上
|
||
海 金 沙 河 股 權
|
||
投資企業(有限
|
||
合夥) (currently
|
||
known as
|
||
Shanghai
|
||
Jinshahe
|
||
Venture Capital
|
||
Partnership
|
||
(Limited
|
||
Partnership) (上
|
||
海 金 沙 河 創 業
|
||
投 資 合 夥 企 業
|
||
(有限合夥)))
|
||
– 9,851,194 3.3% 2.4% October 7,
|
||
2026
|
||
Zhuhai
|
||
Longmen
|
||
Changfeng
|
||
Investment
|
||
Partnership
|
||
(Limited
|
||
Partnership) / 珠
|
||
海 隆 門 長 風 投
|
||
資合夥企業(有
|
||
限合夥)
|
||
4,602,810 4,602,810 1.5% 2.2% October 7,
|
||
2026
|
||
CICC Qide
|
||
(Xiamen)
|
||
Innovation
|
||
Biomedical
|
||
Equity
|
||
Investment Fund
|
||
Partnership
|
||
(Limited
|
||
Partnership) / 中
|
||
金啟德 ( 廈門 )
|
||
創 新 生 物 醫 藥
|
||
股 權 投 資 基 金
|
||
合夥企業 (有限
|
||
2,690,741 6,278,395 2.1% 2.2% October 7,
|
||
2026
|
||
|
||
|
||
--- page 9 ---
|
||
Name
|
||
Number of
|
||
Unlisted
|
||
Shares held in
|
||
the Company
|
||
subject to lock-
|
||
up
|
||
undertakings
|
||
upon Listing
|
||
Number of H
|
||
Shares held in
|
||
the Company
|
||
subject to lock-
|
||
up
|
||
undertakings
|
||
upon Listing
|
||
% of total issued
|
||
H Shares after the
|
||
Global Offering
|
||
subject to lock-up
|
||
undertakings upon
|
||
Listing
|
||
% of
|
||
shareholding
|
||
in the
|
||
Company
|
||
subject to
|
||
lock-up
|
||
undertakings
|
||
upon Listing
|
||
Last day
|
||
subject to the
|
||
lock-up
|
||
undertakings
|
||
Note 11
|
||
合夥) (currently
|
||
known as CICC
|
||
Biomedical
|
||
Fund L.P. (中金
|
||
啟德 ( 廈門 ) 創
|
||
新 生 物 醫 藥 創
|
||
業 投 資 合 夥 企
|
||
業(有限合夥)))
|
||
Shenzhen
|
||
Qianhai
|
||
Yuanming
|
||
Medical
|
||
Industry
|
||
Investment Fund
|
||
(Limited
|
||
Partnership) / 深
|
||
圳 前 海 元 明 醫
|
||
療 產 業 投 資 基
|
||
金(有限合夥)
|
||
– 8,677,133 2.9% 2.1% October 7,
|
||
2026
|
||
Unique Classic
|
||
Limited
|
||
– 8,434,214 2.8% 2.0% October 7,
|
||
2026
|
||
Suzhou
|
||
Longmen No. 1
|
||
Pharmaceutical
|
||
Investment
|
||
Partnership
|
||
(Limited
|
||
Partnership) / 蘇
|
||
州 隆 門 一 號 醫
|
||
藥 投 資 合 夥 企
|
||
業( 有限合夥 )
|
||
Note 4
|
||
– 6,024,439 2.0% 1.5% October 7,
|
||
2026
|
||
Suzhou
|
||
Longmen Yusen
|
||
Venture Capital
|
||
Partnership
|
||
(Limited
|
||
Partnership) / 蘇
|
||
州 隆 門 玉 森 創
|
||
業 投 資 合 夥 企
|
||
業( 有限合夥 )
|
||
Note 4
|
||
– 1,600,001 0.5% 0.4% October 7,
|
||
2026
|
||
|
||
|
||
--- page 10 ---
|
||
Name
|
||
Number of
|
||
Unlisted
|
||
Shares held in
|
||
the Company
|
||
subject to lock-
|
||
up
|
||
undertakings
|
||
upon Listing
|
||
Number of H
|
||
Shares held in
|
||
the Company
|
||
subject to lock-
|
||
up
|
||
undertakings
|
||
upon Listing
|
||
% of total issued
|
||
H Shares after the
|
||
Global Offering
|
||
subject to lock-up
|
||
undertakings upon
|
||
Listing
|
||
% of
|
||
shareholding
|
||
in the
|
||
Company
|
||
subject to
|
||
lock-up
|
||
undertakings
|
||
upon Listing
|
||
Last day
|
||
subject to the
|
||
lock-up
|
||
undertakings
|
||
Note 11
|
||
CCB
|
||
International
|
||
Industrial Fund
|
||
Management
|
||
(Hengqin) Co.,
|
||
Ltd. / 建銀國際
|
||
產 業 基 金 管 理
|
||
( 橫琴 ) 有限公
|
||
司
|
||
– 7,364,496 2.4% 1.8% October 7,
|
||
2026
|
||
Yantai Duoying
|
||
New Kinetic
|
||
Energy
|
||
Investment
|
||
Center (Limited
|
||
Partnership) / 煙
|
||
台 多 盈 新 動 能
|
||
投資中心(有限
|
||
合夥) Note 5
|
||
1,814,664 1,800,000 0.6% 0.9% October 7,
|
||
2026
|
||
Qingdao
|
||
Finnova Energy
|
||
Conservation
|
||
and
|
||
Environmental
|
||
Protection
|
||
Venture
|
||
Investment Fund
|
||
Partnership
|
||
(Limited
|
||
Partnership) / 青
|
||
島 源 創 節 能 環
|
||
保 創 業 投 資 基
|
||
金合夥企業(有
|
||
限合夥) Note 5
|
||
2,314,664 1,300,000 0.4% 0.9% October 7,
|
||
2026
|
||
Shanghai
|
||
Hanren Equity
|
||
Investment
|
||
Center (Limited
|
||
Partnership) / 上
|
||
海 漢 仁 股 權 投
|
||
資中心(有限合
|
||
夥)
|
||
– 7,164,180 2.4% 1.7% October 7,
|
||
2026
|
||
|
||
|
||
--- page 11 ---
|
||
Name
|
||
Number of
|
||
Unlisted
|
||
Shares held in
|
||
the Company
|
||
subject to lock-
|
||
up
|
||
undertakings
|
||
upon Listing
|
||
Number of H
|
||
Shares held in
|
||
the Company
|
||
subject to lock-
|
||
up
|
||
undertakings
|
||
upon Listing
|
||
% of total issued
|
||
H Shares after the
|
||
Global Offering
|
||
subject to lock-up
|
||
undertakings upon
|
||
Listing
|
||
% of
|
||
shareholding
|
||
in the
|
||
Company
|
||
subject to
|
||
lock-up
|
||
undertakings
|
||
upon Listing
|
||
Last day
|
||
subject to the
|
||
lock-up
|
||
undertakings
|
||
Note 11
|
||
Changzhou
|
||
Feijun
|
||
Longcheng
|
||
Equity
|
||
Investment
|
||
Partnership
|
||
(Limited
|
||
Partnership) / 常
|
||
州 斐 君 隆 成 股
|
||
權 投 資 合 夥 企
|
||
業( 有限合夥 )
|
||
Note 6
|
||
– 2,904,067 0.1% 0.7% October 7,
|
||
2026
|
||
Ningbo Feijun
|
||
Yuanchuan
|
||
Equity
|
||
Investment
|
||
Partnership
|
||
(Limited
|
||
Partnership) / 寧
|
||
波 斐 君 元 川 股
|
||
權 投 資 合 夥 企
|
||
業( 有限合夥 )
|
||
Note 6
|
||
– 1,566,350 0.5% 3.7% October 7,
|
||
2026
|
||
Guangzhou
|
||
Huangpu
|
||
Yongping
|
||
Science and
|
||
Technology
|
||
Equity
|
||
Investment
|
||
Partnership
|
||
(Limited
|
||
Partnership) / 廣
|
||
州 黃 埔 永 平 科
|
||
創股權 投資合
|
||
夥企業(有限合
|
||
夥) Note 6
|
||
– 1,106,582 0.4% 0.3% October 7,
|
||
2026
|
||
Changzhou
|
||
Feijun Yongjun
|
||
Equity
|
||
Investment
|
||
Partnership
|
||
(Limited
|
||
– 1,106,582 0.4% 0.3% October 7,
|
||
2026
|
||
|
||
|
||
--- page 12 ---
|
||
Name
|
||
Number of
|
||
Unlisted
|
||
Shares held in
|
||
the Company
|
||
subject to lock-
|
||
up
|
||
undertakings
|
||
upon Listing
|
||
Number of H
|
||
Shares held in
|
||
the Company
|
||
subject to lock-
|
||
up
|
||
undertakings
|
||
upon Listing
|
||
% of total issued
|
||
H Shares after the
|
||
Global Offering
|
||
subject to lock-up
|
||
undertakings upon
|
||
Listing
|
||
% of
|
||
shareholding
|
||
in the
|
||
Company
|
||
subject to
|
||
lock-up
|
||
undertakings
|
||
upon Listing
|
||
Last day
|
||
subject to the
|
||
lock-up
|
||
undertakings
|
||
Note 11
|
||
Partnership) / 常
|
||
州 斐 君 永 君 股
|
||
權 投 資 合 夥 企
|
||
業(有限合夥))
|
||
Note 6
|
||
Anhui Xin’an
|
||
Cornerstone
|
||
Industry
|
||
Upgrade Fund
|
||
Partnership
|
||
(Limited
|
||
Partnership) / 安
|
||
徽 信 安 基 石 產
|
||
業 升 級 基 金 合
|
||
夥企業(有限合
|
||
夥)
|
||
6,024,439 – – 1.5% October 7,
|
||
2026
|
||
Shanghai Jinpu
|
||
Guotiao Merger
|
||
Equity
|
||
Investment Fund
|
||
Partnership
|
||
(Limited
|
||
Partnership) / 上
|
||
海 金 浦 國 調 併
|
||
購 股 權 投 資 基
|
||
金合夥企業
|
||
(有限合夥)
|
||
– 5,532,910 1.8% 1.3% October 7,
|
||
2026
|
||
Shanghai Jianli
|
||
Investment
|
||
Partnership
|
||
(Limited
|
||
Partnership) / 上
|
||
海 簡 理 投 資 合
|
||
夥企業(有限合
|
||
夥)
|
||
– 3,682,248 1.2% 0.9% October 7,
|
||
2026
|
||
Suzhou Mengxi
|
||
Venture
|
||
Investment
|
||
Center (Limited
|
||
Partnership) / 蘇
|
||
州 孟 溪 創 業 投
|
||
– 3,614,664 1.2% 0.9% October 7,
|
||
2026
|
||
|
||
|
||
--- page 13 ---
|
||
Name
|
||
Number of
|
||
Unlisted
|
||
Shares held in
|
||
the Company
|
||
subject to lock-
|
||
up
|
||
undertakings
|
||
upon Listing
|
||
Number of H
|
||
Shares held in
|
||
the Company
|
||
subject to lock-
|
||
up
|
||
undertakings
|
||
upon Listing
|
||
% of total issued
|
||
H Shares after the
|
||
Global Offering
|
||
subject to lock-up
|
||
undertakings upon
|
||
Listing
|
||
% of
|
||
shareholding
|
||
in the
|
||
Company
|
||
subject to
|
||
lock-up
|
||
undertakings
|
||
upon Listing
|
||
Last day
|
||
subject to the
|
||
lock-up
|
||
undertakings
|
||
Note 11
|
||
資中心(有限合
|
||
夥)
|
||
Tianjin Yuanyi
|
||
Kaiyuan Asset
|
||
Management
|
||
Center (Limited
|
||
Partnership) / 天
|
||
津 遠 翼 開 元 資
|
||
產管理中心(有
|
||
限合夥)
|
||
– 3,614,657 1.2% 0.9% October 7,
|
||
2026
|
||
Langma No. 18
|
||
(Shenzhen)
|
||
Venture Capital
|
||
Center (Limited
|
||
Partnership) / 朗
|
||
瑪十八號 ( 深
|
||
圳)創業投資中
|
||
心( 有限合夥 )
|
||
Note 7
|
||
– 2,289,283 0.8% 0.6% October 7,
|
||
2026
|
||
Langma No. 17
|
||
(Shenzhen)
|
||
Venture Capital
|
||
Center (Limited
|
||
Partnership) / 朗
|
||
瑪十七號 ( 深
|
||
圳)創業投資中
|
||
心( 有限合夥 )
|
||
Note 7
|
||
– 1,325,374 0.4% 0.3% October 7,
|
||
2026
|
||
Chengdu
|
||
Boyuan Jiayu
|
||
Venture Capital
|
||
Partnership
|
||
(Limited
|
||
Partnership) / 成
|
||
都 博 遠 嘉 昱 創
|
||
業 投資合夥企
|
||
業(有限合夥)
|
||
– 3,319,747 1.1% 0.8% October 7,
|
||
2026
|
||
Shanghai
|
||
Yangtze River
|
||
Delta Industry
|
||
Upgrade Equity
|
||
Investment
|
||
– 3,319,747 1.1% 0.8% October 7,
|
||
2026
|
||
|
||
|
||
--- page 14 ---
|
||
Name
|
||
Number of
|
||
Unlisted
|
||
Shares held in
|
||
the Company
|
||
subject to lock-
|
||
up
|
||
undertakings
|
||
upon Listing
|
||
Number of H
|
||
Shares held in
|
||
the Company
|
||
subject to lock-
|
||
up
|
||
undertakings
|
||
upon Listing
|
||
% of total issued
|
||
H Shares after the
|
||
Global Offering
|
||
subject to lock-up
|
||
undertakings upon
|
||
Listing
|
||
% of
|
||
shareholding
|
||
in the
|
||
Company
|
||
subject to
|
||
lock-up
|
||
undertakings
|
||
upon Listing
|
||
Last day
|
||
subject to the
|
||
lock-up
|
||
undertakings
|
||
Note 11
|
||
Partnership
|
||
(Limited
|
||
Partnership) / 上
|
||
海 長 三 角 產 業
|
||
升 級 股 權 投 資
|
||
合夥企業(有限
|
||
合夥)
|
||
Changzhou
|
||
Feijun Equity
|
||
Investment
|
||
Partnership
|
||
(Limited
|
||
Partnership) / 常
|
||
州 斐 君 股 權 投
|
||
資合夥企業
|
||
(有限合夥) Note
|
||
8
|
||
– 2,409,773 0.8% 0.6% October 7,
|
||
2026
|
||
Guangzhou
|
||
Huangpu Feijun
|
||
Industry
|
||
Investment Fund
|
||
Partnership
|
||
(Limited
|
||
Partnership) / 廣
|
||
州 黃 埔 斐 君 產
|
||
業 投 資 基 金 合
|
||
夥企業(有限合
|
||
夥) Note 8
|
||
– 843,420 0.3% 0.2% October 7,
|
||
2026
|
||
Shenzhen
|
||
Qianhai Kangda
|
||
Science and
|
||
Technology
|
||
Venture
|
||
Investment
|
||
Partnership
|
||
(Limited
|
||
Partnership) / 深
|
||
圳 前 海 康 達 科
|
||
技 創 業 投 資 合
|
||
夥企業(有限合
|
||
夥)
|
||
– 2,379,151 0.8% 0.6% October 7,
|
||
2026
|
||
|
||
|
||
--- page 15 ---
|
||
Name
|
||
Number of
|
||
Unlisted
|
||
Shares held in
|
||
the Company
|
||
subject to lock-
|
||
up
|
||
undertakings
|
||
upon Listing
|
||
Number of H
|
||
Shares held in
|
||
the Company
|
||
subject to lock-
|
||
up
|
||
undertakings
|
||
upon Listing
|
||
% of total issued
|
||
H Shares after the
|
||
Global Offering
|
||
subject to lock-up
|
||
undertakings upon
|
||
Listing
|
||
% of
|
||
shareholding
|
||
in the
|
||
Company
|
||
subject to
|
||
lock-up
|
||
undertakings
|
||
upon Listing
|
||
Last day
|
||
subject to the
|
||
lock-up
|
||
undertakings
|
||
Note 11
|
||
Pingtan
|
||
Comprehensive
|
||
Experimental
|
||
Zone Watson
|
||
Huijia Equity
|
||
Investment
|
||
Partnership
|
||
(Limited
|
||
Partnership) / 平
|
||
潭 綜 合 實 驗 區
|
||
沃 生 慧 嘉 股 權
|
||
投 資 合 夥 企 業
|
||
(有限合夥)
|
||
– 2,213,165 0.7% 0.5% October 7,
|
||
2026
|
||
Wuhu Taichu
|
||
Investment
|
||
Partnership
|
||
(Limited
|
||
Partnership / 蕪
|
||
湖 太 初 投 資 合
|
||
夥企業(有限合
|
||
夥)
|
||
1,106,582 1,106,583 0.4% 0.5% October 7,
|
||
2026
|
||
Yangzhou
|
||
Tenglan Equity
|
||
Investment
|
||
Partnership
|
||
(Limited
|
||
Partnership) / 揚
|
||
州 騰 嵐 股 權 投
|
||
資合夥企業
|
||
(有限合夥) Note
|
||
9
|
||
– 1,770,532 0.6% 0.4% October 7,
|
||
2026
|
||
Changzhou
|
||
Tengren Equity
|
||
Investment
|
||
Partnership
|
||
(Limited
|
||
Partnership) / 常
|
||
州 騰 壬 股 權 投
|
||
資合夥企業(有
|
||
限合夥) Note 9
|
||
– 442,633 0.1% 0.1% October 7,
|
||
2026
|
||
Wuxi Lejin
|
||
Fengyun
|
||
1,841,124 – – 0.4% October 7,
|
||
2026
|
||
|
||
|
||
--- page 16 ---
|
||
Name
|
||
Number of
|
||
Unlisted
|
||
Shares held in
|
||
the Company
|
||
subject to lock-
|
||
up
|
||
undertakings
|
||
upon Listing
|
||
Number of H
|
||
Shares held in
|
||
the Company
|
||
subject to lock-
|
||
up
|
||
undertakings
|
||
upon Listing
|
||
% of total issued
|
||
H Shares after the
|
||
Global Offering
|
||
subject to lock-up
|
||
undertakings upon
|
||
Listing
|
||
% of
|
||
shareholding
|
||
in the
|
||
Company
|
||
subject to
|
||
lock-up
|
||
undertakings
|
||
upon Listing
|
||
Last day
|
||
subject to the
|
||
lock-up
|
||
undertakings
|
||
Note 11
|
||
Investment
|
||
Enterprise
|
||
(Limited
|
||
Partnership) / 無
|
||
錫 樂 金 風 雲 投
|
||
資企業(有限合
|
||
夥)
|
||
Ningbo Meishan
|
||
Free Trade Port
|
||
Xinfei Dingke
|
||
Investment
|
||
Management
|
||
Partnership
|
||
(Limited
|
||
Partnership) / 寧
|
||
波 梅 山 保 稅 港
|
||
區 新 菲 鼎 柯 投
|
||
資 管 理 合 夥 企
|
||
業( 有限合夥 )
|
||
Note 10
|
||
– 1,196,731 0.4% 0.3% October 7,
|
||
2026
|
||
Xinyu Xinding
|
||
Kenge No. 12
|
||
Investment
|
||
Management
|
||
Partnership
|
||
(Limited
|
||
Partnership) (新
|
||
余 新 鼎 啃 哥 拾
|
||
貳 號 投 資 管 理
|
||
合夥企業 (有
|
||
限合夥)) Note 10
|
||
– 552,338 0.2% 0.1% October 7,
|
||
2026
|
||
Suzhou
|
||
Yueliang
|
||
Enterprise
|
||
Management
|
||
Partnership
|
||
(Limited
|
||
Partnership) (蘇
|
||
州 閱 良 企 業 管
|
||
理合夥企業(有
|
||
限合夥 ))
|
||
(formerly known
|
||
– 1,483,445 0.5% 0.4% October 7,
|
||
2026
|
||
|
||
|
||
--- page 17 ---
|
||
Name
|
||
Number of
|
||
Unlisted
|
||
Shares held in
|
||
the Company
|
||
subject to lock-
|
||
up
|
||
undertakings
|
||
upon Listing
|
||
Number of H
|
||
Shares held in
|
||
the Company
|
||
subject to lock-
|
||
up
|
||
undertakings
|
||
upon Listing
|
||
% of total issued
|
||
H Shares after the
|
||
Global Offering
|
||
subject to lock-up
|
||
undertakings upon
|
||
Listing
|
||
% of
|
||
shareholding
|
||
in the
|
||
Company
|
||
subject to
|
||
lock-up
|
||
undertakings
|
||
upon Listing
|
||
Last day
|
||
subject to the
|
||
lock-up
|
||
undertakings
|
||
Note 11
|
||
as Shanghai
|
||
Yueliang
|
||
Enterprise
|
||
Management
|
||
Partnership
|
||
(Limited
|
||
Partnership) (上
|
||
海 閱 良 企 業 管
|
||
理合夥企業(有
|
||
限合夥)))
|
||
Suzhou
|
||
Shengyuan
|
||
Enterprise
|
||
Management
|
||
Center (Limited
|
||
Partnership) ( 蘇
|
||
州 晟 源 企 業 管
|
||
理中心(有限合
|
||
夥))
|
||
575,423 863,135 0.3% 0.3% October 7,
|
||
2026
|
||
Ms. CHEN
|
||
Xiangyun
|
||
804,884 400,000 0.1% 0.3% October 7,
|
||
2026
|
||
Guangzhou
|
||
Xinxing Venture
|
||
Capital
|
||
Partnership
|
||
(Limited
|
||
Partnership)
|
||
(廣州新星創業
|
||
投 資 合 夥 企 業
|
||
( 有 限 合 夥 ))
|
||
(currently
|
||
known as
|
||
Guangzhou
|
||
Xinxing
|
||
Huacheng
|
||
Venture Capital
|
||
Partnership
|
||
(Limited
|
||
Partnership) (廣
|
||
州 新 星 花 城 創
|
||
業 投 資 合 夥 企
|
||
業(有限合夥)))
|
||
– 1,106,582 0.4% 0.3% October 7,
|
||
2026
|
||
|
||
|
||
--- page 18 ---
|
||
Name
|
||
Number of
|
||
Unlisted
|
||
Shares held in
|
||
the Company
|
||
subject to lock-
|
||
up
|
||
undertakings
|
||
upon Listing
|
||
Number of H
|
||
Shares held in
|
||
the Company
|
||
subject to lock-
|
||
up
|
||
undertakings
|
||
upon Listing
|
||
% of total issued
|
||
H Shares after the
|
||
Global Offering
|
||
subject to lock-up
|
||
undertakings upon
|
||
Listing
|
||
% of
|
||
shareholding
|
||
in the
|
||
Company
|
||
subject to
|
||
lock-up
|
||
undertakings
|
||
upon Listing
|
||
Last day
|
||
subject to the
|
||
lock-up
|
||
undertakings
|
||
Note 11
|
||
Guangzhou
|
||
Zhiyuan
|
||
Xinxing Equity
|
||
Investment
|
||
Partnership
|
||
(Limited
|
||
Partnership) ( 廣
|
||
州 致 遠 新 星 股
|
||
權 投 資 合 夥 企
|
||
業(有限合夥))
|
||
– 1,106,582 0.4% 0.3% October 7,
|
||
2026
|
||
Suzhou
|
||
Wosheng
|
||
Enterprise
|
||
Management
|
||
Center (Limited
|
||
Partnership) ( 蘇
|
||
州 沃 昇 企 業 管
|
||
理中心(有限合
|
||
夥))
|
||
– 644,393 0.2% 0.2% October 7,
|
||
2026
|
||
Shenzhen CMB
|
||
Gongying
|
||
Equity
|
||
Investment
|
||
Partnership
|
||
Enterprise
|
||
(Limited
|
||
Partnership) ( 深
|
||
圳 市 招 銀 共 贏
|
||
股 權 投 資 合 夥
|
||
企業 ( 有 限 合
|
||
夥))
|
||
394,030 – – 0.1% October 7,
|
||
2026
|
||
Mr. MI Jinyong – 210,612 0.1% 0.1% October 7,
|
||
2026
|
||
Mr. GENG
|
||
Shaofeng
|
||
– 210,610 0.1% 0.1% October 7,
|
||
2026
|
||
Subtotal 69,334,378 200,394,953 66.3% 65.5%
|
||
|
||
* denotes less than 0.05%
|
||
|
||
Notes:
|
||
|
||
1. Each an investment arm of Oriza Funds.
|
||
|
||
2. Each an investment arm of CMB Funds.
|
||
|
||
|
||
--- page 19 ---
|
||
Name
|
||
Number of
|
||
Unlisted
|
||
Shares held in
|
||
the Company
|
||
subject to lock-
|
||
up
|
||
undertakings
|
||
upon Listing
|
||
Number of H
|
||
Shares held in
|
||
the Company
|
||
subject to lock-
|
||
up
|
||
undertakings
|
||
upon Listing
|
||
% of total issued
|
||
H Shares after the
|
||
Global Offering
|
||
subject to lock-up
|
||
undertakings upon
|
||
Listing
|
||
% of
|
||
shareholding
|
||
in the
|
||
Company
|
||
subject to
|
||
lock-up
|
||
undertakings
|
||
upon Listing
|
||
Last day
|
||
subject to the
|
||
lock-up
|
||
undertakings
|
||
Note 11
|
||
|
||
3. Each an investment arm of GTJA Investment Group.
|
||
|
||
4. Each an investment arm of Suzhou Longmen Venture Capital.
|
||
|
||
5. Each an investment arm of Finnova Funds.
|
||
|
||
6. Each an investment arm of Mild Investment.
|
||
|
||
7. Each an investment arm of Everest Ventures.
|
||
|
||
8. Each an investment arm of Feijun Investment.
|
||
|
||
9. Each an investment arm of Tengwu Investment.
|
||
|
||
10. Each an investment arm of Xinding Capital.
|
||
|
||
11. The expiry date of the lock-up period shown in the table above is pursuant to the PRC Company Laws. In accordance
|
||
with the relevant Listing Rules/guidance materials, the required lock-up for existing Shareholders ends on October 7,
|
||
2026, being 12 months following the Listing Date.
|
||
|
||
|
||
--- page 20 ---
|
||
PLACEE CONCENTRATION ANALYSIS
|
||
Placees
|
||
Number of H
|
||
Shares allotted
|
||
|
||
Allotment as % of
|
||
International Offering
|
||
Allotment as % of total
|
||
Offer Shares
|
||
Number of
|
||
Shares held upon Listing
|
||
|
||
% of total issued share
|
||
capital upon Listing
|
||
Top 1 12,130,500 32.72% 29.44% 12,130,500 2.94%
|
||
Top 5 29,927,500 80.71% 72.64% 29,927,500 7.26%
|
||
Top 10 33,358,000 89.97% 80.97% 36,611,193 8.89%
|
||
Top 25 36,169,000 97.55% 87.79% 39,422,193 9.57%
|
||
|
||
Note:
|
||
* Ranking of placees is based on the number of H Shares allotted to the placees.
|
||
H SHAREHOLDERS CONCENTRATION ANALYSIS
|
||
H
|
||
Shareholders*
|
||
Number of H
|
||
Shares allotted
|
||
|
||
Allotment as % of
|
||
International Offering
|
||
Allotment as % of
|
||
total Offer Shares
|
||
Number of H Shares
|
||
held upon Listing
|
||
|
||
% of total issued H
|
||
Shares capital upon
|
||
Listing
|
||
Number of Shares
|
||
held upon Listing
|
||
|
||
Top 1 0 0.00% 0.00% 60,630,633 20.06% 101,051,056
|
||
Top 5 12,130,500 32.72% 29.44% 134,230,700 44.41% 174,651,123
|
||
Top 10 22,977,500 61.97% 55.77% 185,732,828 61.46% 226,153,251
|
||
Top 25 23,791,000 64.16% 57.75% 266,030,094 88.02% 332,077,755
|
||
|
||
Note:
|
||
* Ranking of H Shareholders is based on the number of H Shares held by the H Shareholders upon Listing.
|
||
SHAREHOLDER CONCENTRATION ANALYSIS
|
||
Shareholders
|
||
Number of H
|
||
Shares allotted
|
||
|
||
Allotment as % of
|
||
International Offering
|
||
Allotment as % of
|
||
total Offer Shares
|
||
Number of H Shares
|
||
held upon Listing
|
||
Number of Shares
|
||
held upon Listing
|
||
|
||
% of total issued
|
||
share capital upon
|
||
Listing
|
||
Top 1 0 0.00% 0.00% 60,630,633 101,051,056 24.53%
|
||
Top 5 0 0.00% 0.00% 126,650,200 177,686,276 43.13%
|
||
Top 10 12,130,500 32.72% 29.44% 162,324,481 242,191,887 58.79%
|
||
Top 25 23,791,000 64.16% 57.75% 255,261,286 360,294,044 87.45%
|
||
|
||
Note:
|
||
|
||
|
||
--- page 21 ---
|
||
* Ranking of Shareholders is based on the number of Shares (of all classes) held by the Shareholder s upon Listing.
|
||
|
||
BASIS OF ALLOCATION UNDER THE HONG KONG PUBLIC OFFERING
|
||
Subject to the satisfaction of the conditions set out in the Prospectus, valid applications made by
|
||
the public will be conditionally allocated on the basis set out below:
|
||
NO. OF H SHARES
|
||
APPLIED FOR
|
||
NO. OF VALID
|
||
APPLICATIONS
|
||
BASIS OF
|
||
ALLOTMENT/BALLOT
|
||
APPROXIMATE
|
||
PERCENTAGE OF
|
||
ALLOTTED SHARES
|
||
OF THE TOTAL NO.
|
||
OF SHARES
|
||
APPLIED FOR
|
||
POOL A
|
||
500 83,975 840 out of 83,975 to receive 500 Shares 1.00%
|
||
1,000 19,181 193 out of 19,181 to receive 500 Shares 0.50%
|
||
1,500 9,535 97 out of 9,535 to receive 500 Shares 0.34%
|
||
2,000 7,889 82 out of 7,889 to receive 500 Shares 0.26%
|
||
2,500 6,257 66 out of 6,257 to receive 500 Shares 0.21%
|
||
3,000 8,435 91 out of 8,435 to receive 500 Shares 0.18%
|
||
3,500 2,718 30 out of 2,718 to receive 500 Shares 0.16%
|
||
4,000 2,956 33 out of 2,956 to receive 500 Shares 0.14%
|
||
4,500 2,051 24 out of 2,051 to receive 500 Shares 0.13%
|
||
5,000 9,073 109 out of 9,073 to receive 500 Shares 0.12%
|
||
6,000 4,702 57 out of 4,702 to receive 500 Shares 0.10%
|
||
7,000 3,636 45 out of 3,636 to receive 500 Shares 0.09%
|
||
8,000 2,535 32 out of 2,535 to receive 500 Shares 0.08%
|
||
9,000 2,102 28 out of 2,102 to receive 500 Shares 0.07%
|
||
10,000 9,251 128 out of 9,251 to receive 500 Shares 0.07%
|
||
15,000 5,904 114 out of 5,904 to receive 500 Shares 0.06%
|
||
20,000 4,843 110 out of 4,843 to receive 500 Shares 0.06%
|
||
25,000 3,822 87 out of 3,822 to receive 500 Shares 0.05%
|
||
30,000 3,701 100 out of 3,701 to receive 500 Shares 0.05%
|
||
35,000 2,778 78 out of 2,778 to receive 500 Shares 0.04%
|
||
40,000 2,463 71 out of 2,463 to receive 500 Shares 0.04%
|
||
45,000 1,957 58 out of 1,957 to receive 500 Shares 0.03%
|
||
50,000 4,353 130 out of 4,353 to receive 500 Shares 0.03%
|
||
60,000 3,165 95 out of 3,165 to receive 500 Shares 0.03%
|
||
70,000 2,635 82 out of 2,635 to receive 500 Shares 0.02%
|
||
80,000 1,989 62 out of 1,989 to receive 500 Shares 0.02%
|
||
90,000 1,733 55 out of 1,733 to receive 500 Shares 0.02%
|
||
100,000 11,553 368 out of 11,553 to receive 500 Shares 0.02%
|
||
200,000 7,222 295 out of 7,222 to receive 500 Shares 0.01%
|
||
300,000 10,501 560 out of 10,501 to receive 500 Shares 0.01%
|
||
242,915 Total number of Pool A successful applicants: 4 ,120
|
||
|
||
POOL B
|
||
400,000 5,262 437 out of 5,262 to receive 500 Shares 0.01%
|
||
500,000 2,606 270 out of 2,606 to receive 500 Shares 0.01%
|
||
600,000 1,881 234 out of 1,881 to receive 500 Shares 0.01%
|
||
700,000 1,497 217 out of 1,497 to receive 500 Shares 0.01%
|
||
800,000 1,162 193 out of 1,162 to receive 500 Shares 0.01%
|
||
|
||
|
||
--- page 22 ---
|
||
NO. OF H SHARES
|
||
APPLIED FOR
|
||
NO. OF VALID
|
||
APPLICATIONS
|
||
BASIS OF
|
||
ALLOTMENT/BALLOT
|
||
APPROXIMATE
|
||
PERCENTAGE OF
|
||
ALLOTTED SHARES
|
||
OF THE TOTAL NO.
|
||
OF SHARES
|
||
APPLIED FOR
|
||
900,000 842 157 out of 842 to receive 500 Shares 0.01%
|
||
1,000,000 2,874 596 out of 2,874 to receive 500 Shares 0.01%
|
||
1,500,000 1,656 515 out of 1,656 to receive 500 Shares 0.01%
|
||
2,060,000 3,514 1,501 out of 3,514 to receive 500
|
||
Shares
|
||
0.01%
|
||
21,294 Total number of Pool B successful applicants: 4,120
|
||
|
||
|
||
As of the date of this announcement, the relevant subscription monies previously deposited in the
|
||
designated nominee accounts have been remitted back to the accounts of all HKSCC participants.
|
||
Investors should contact their relevant brokers for any inquiries.
|
||
|
||
|
||
COMPLIANCE WITH LISTING RULES AND GUIDANCE
|
||
The Directors confirm that, except for the Listing Rules that have been waived and/or in respect of
|
||
which consent has been obtained, the Company has complied with the Listing Rules and guidance
|
||
materials in relation to the placing, allotment and listing of the Company’s H Shares.
|
||
The Directors confirm that, to the best of their knowledge, the consideration payable by the placees or
|
||
the public (as the case maybe) directly or indirectly for each Offer Share subscribed for or purchased
|
||
by them was the same as the Offer Price in addition to any brokerage, AFRC transaction levy, SFC
|
||
transaction levy and trading fee payable.
|
||
|
||
OTHERS/ADDITIONAL INFORMATION
|
||
Placing to a close associate of existing Shareholders with prior consent under paragraph 1C(2)
|
||
of Appendix F1 to the Listing Rules (the Placing Guidelines)
|
||
Mr. Huang
|
||
The Company has applied to the Stock Exchange for, and the Stock Exchange has granted, a consent
|
||
under paragraph 1C(2) of the Placing Guidelines to permit the Company to allocate such Offer Shares
|
||
in the International Offering to Mr. Huang.
|
||
Mr. Huang is a close associate of Changzhou Feijun Equity Investment Partnership (Limited
|
||
Partnership) ( 常州斐君股權投資合夥企業(有限合夥)) and Guangzhou Huangpu Feijun Industry
|
||
Investment Fund Partnership (Limited Partnership) ( 廣州黃埔斐君產業投資基金合夥企業(有限
|
||
合夥)), both of which are existing Shareholders of the Company.
|
||
The allocation of the Offer Shares to Mr. Huang is in compliance with all the conditions under the
|
||
consent granted by the Stock Exchange, including but not limited to that no preferential treatment was
|
||
given to Mr. Huang in the allocation process by virtue of his relationship with the Company.
|
||
|
||
|
||
--- page 23 ---
|
||
For details of the allocations of Offer Shares to Mr. Huang, please refer to the section headed
|
||
“Allotment Results Details – International Offering – Allotees with Waivers/Cons ents Obtained” in
|
||
this announcement.
|
||
|
||
Placing to connected clients with a prior consent under paragraph 1C(1) of Appendix F1 to the
|
||
Listing Rules (the Placing Guidelines)
|
||
The Company has applied to the Stock Exchange for, and the Stock Exchange has granted, a consent
|
||
under paragraph 1C(1) of the Placing Guidelines to permit the Company to allocate such Offer Shares
|
||
in the International Offering to CSICM, China AMC HK, CMBI SG and Bosera AM, each of which
|
||
is a connected client of certain distributors. Please also refer to the section below headed “Placing to
|
||
connected clients with a prior consent under paragraph 1C(1) of the Placing Guidelines” for details.
|
||
Under the International Offering, certain Offer Shares were placed to certain connected clients of their
|
||
connected distributors pursuant to the Placing Guidelines. Please refer to the section headed
|
||
“Allotment Results Details – International Offering – Allotees with Waivers/Consents Obtained” in
|
||
this announcement for details. The Co mpany has applied to the Stock Exchange for, and the Stock
|
||
Exchange has granted, a consent under paragraph 1C(1) of the Placing Guidelines to permit the
|
||
Company to allocate such Offer Shares in the International Offering to certain connected clients. The
|
||
allocation of Offer Shares to such connected clients is in compliance with all the conditions under the
|
||
consent granted by the Stock Exchange. Details of the placement to connected clients are set out below.
|
||
No.
|
||
Connected
|
||
Client
|
||
Connected
|
||
Distributor
|
||
Relationship
|
||
with the
|
||
Connected
|
||
Distributor
|
||
Whether the
|
||
connected client
|
||
will hold
|
||
beneficial
|
||
interests of Offer
|
||
Shares on a
|
||
nondiscretionary
|
||
or discretionary
|
||
basis for
|
||
independent
|
||
third parties
|
||
Number
|
||
of Offer
|
||
Shares to
|
||
be
|
||
allocated
|
||
to the
|
||
connected
|
||
client
|
||
Appropriate
|
||
percentage
|
||
of total
|
||
number of
|
||
Offer
|
||
Shares
|
||
Approximate
|
||
percentage
|
||
of total
|
||
issued share
|
||
capital
|
||
immediately
|
||
following the
|
||
completion
|
||
of Global
|
||
Offering
|
||
1. CSICM
|
||
(Note 1)
|
||
CLSA Limited
|
||
(“CLSA”)
|
||
CSICM is a
|
||
member of
|
||
the same
|
||
group of
|
||
CLSA.
|
||
Non-
|
||
discretionary
|
||
basis
|
||
5,000 0.0121% 0.0012%
|
||
2. China
|
||
AMC HK
|
||
(Note 2)
|
||
CLSA China AMC
|
||
HK is a
|
||
member of
|
||
the same
|
||
group of
|
||
CLSA.
|
||
Discretionary
|
||
basis
|
||
5,000 0.0121% 0.0012%
|
||
3. CMBI SG
|
||
(Note 3)
|
||
CMB
|
||
International
|
||
Capital
|
||
Limited
|
||
(“CMBI”),
|
||
CMB
|
||
International
|
||
Securities
|
||
Limited
|
||
(“CMBI
|
||
Securities”)
|
||
CMBI SG is
|
||
a member of
|
||
the same
|
||
group with
|
||
CMBI,
|
||
CMBI
|
||
Securities
|
||
and CMBI
|
||
Global
|
||
Markets.
|
||
Discretionary
|
||
basis
|
||
10,500 0.0255% 0.0025%
|
||
|
||
|
||
--- page 24 ---
|
||
No.
|
||
Connected
|
||
Client
|
||
Connected
|
||
Distributor
|
||
Relationship
|
||
with the
|
||
Connected
|
||
Distributor
|
||
Whether the
|
||
connected client
|
||
will hold
|
||
beneficial
|
||
interests of Offer
|
||
Shares on a
|
||
nondiscretionary
|
||
or discretionary
|
||
basis for
|
||
independent
|
||
third parties
|
||
Number
|
||
of Offer
|
||
Shares to
|
||
be
|
||
allocated
|
||
to the
|
||
connected
|
||
client
|
||
Appropriate
|
||
percentage
|
||
of total
|
||
number of
|
||
Offer
|
||
Shares
|
||
Approximate
|
||
percentage
|
||
of total
|
||
issued share
|
||
capital
|
||
immediately
|
||
following the
|
||
completion
|
||
of Global
|
||
Offering
|
||
and CMB
|
||
International
|
||
Global
|
||
Markets
|
||
Limited
|
||
(“CMBI
|
||
Global
|
||
Markets”,
|
||
together with
|
||
CMBI and
|
||
CMBI
|
||
Securities, the
|
||
“CMBI
|
||
Connected
|
||
Distributors”)
|
||
4. Bosera
|
||
AM (Note 4)
|
||
CMBI
|
||
Connected
|
||
Distributors
|
||
Bosera AM
|
||
is a member
|
||
of the same
|
||
group with
|
||
CMBI,
|
||
CMBI
|
||
Securities
|
||
and CMBI
|
||
Global
|
||
Markets.
|
||
Discretionary
|
||
basis
|
||
10,500 0.0255% 0.0025%
|
||
Notes:
|
||
|
||
1. PRC investors are currently not permitted under applicable PRC laws to participate directly in initial public
|
||
offerings (“IPOs”) in Hong Kong. However, PRC investors are permitted to invest in products issued by
|
||
appropriate domestic securities firms licensed to undertake cross -border derivatives trading activities. In
|
||
connection with such products, the licensed do mestic securities firms, through their Hong Kong affiliates,
|
||
may participate in Hong Kong IPOs either as placees or cornerstone investors (the “ Cross-border
|
||
Derivatives Trading Regime”).
|
||
|
||
CITIC Securities Company Limited (“ CITIC Securities ”), the shares of which are listed on both the
|
||
Shanghai Stock Exchange (stock code: 600030) and the Stock Exchange (stock code: 6030), is one of the
|
||
domestic securities firms licensed to undertake cross-border derivatives trading activities. CITIC Securities
|
||
entered into an International Swaps and Derivatives Association agreement (the “ISDA Agreement”) with
|
||
its indirectly wholly-owned subsidiary, CSICM to set out the principal terms of any future total return swap
|
||
between CITIC Securities and CSICM.
|
||
|
||
CLSA is an Overall Coordinator, Joint Global Coordinator, Joint Bookrunner and Joint Lead Manager in
|
||
connection with the Global Offering. Pursuant to the ISDA Agreement, CSICM, which intends to participate
|
||
in the Global Offering as a placee, will hold the Offer Shares on a non-discretionary basis as the single
|
||
underlying holder under a back -to-back total return swap (the “ Back-to-back TRS ”) to be entered by
|
||
CSICM with CITIC Securities in connection with a Client TRS (as defined below) placed by and fully funded
|
||
(i.e. with no financing provided by CSICM) by the CSICM Ultimate Client (as defined below), pursuant to
|
||
which CSICM will pass the full economic exposure of the Offer Shares to the CSICM Ultimate Client, which
|
||
in effect, CSICM will hold the beneficial interest of the Offer Shares on behalf of the CSICM Ultimate Client.
|
||
CSICM is indirectly wholly owned by CITIC Securities. CLSA is also indirectly wholly owned by CITIC
|
||
|
||
|
||
--- page 25 ---
|
||
No.
|
||
Connected
|
||
Client
|
||
Connected
|
||
Distributor
|
||
Relationship
|
||
with the
|
||
Connected
|
||
Distributor
|
||
Whether the
|
||
connected client
|
||
will hold
|
||
beneficial
|
||
interests of Offer
|
||
Shares on a
|
||
nondiscretionary
|
||
or discretionary
|
||
basis for
|
||
independent
|
||
third parties
|
||
Number
|
||
of Offer
|
||
Shares to
|
||
be
|
||
allocated
|
||
to the
|
||
connected
|
||
client
|
||
Appropriate
|
||
percentage
|
||
of total
|
||
number of
|
||
Offer
|
||
Shares
|
||
Approximate
|
||
percentage
|
||
of total
|
||
issued share
|
||
capital
|
||
immediately
|
||
following the
|
||
completion
|
||
of Global
|
||
Offering
|
||
Securities. Therefore, CSICM is a member of the same group of companies as CLSA. Accordingly, CSICM
|
||
is considered as a “connected client” of CLSA pursuant to paragraph 1B(7) of the Placing Guidelines.
|
||
|
||
Pursuant to the Cross -border Derivatives Trading Regime, the onshore investor (the “CSICM Ultimate
|
||
Client”) cannot directly subscribe for the Offer Shares but may invest in derivative products issued by
|
||
domestic securities firms licenced to undertake cross -border derivatives trading activities, such as CITIC
|
||
Securities, with the Offer Shares as the underlying assets. Instead of directly subscribing for the Offer
|
||
Shares, the CSICM Ultimate Client will subscribe for the Offer Shares, the CSICM Ultimate Client will
|
||
place a total return swap order (the “Client TRS”) with CITIC Securities in connection with the Company’s
|
||
IPO and CITIC Securities will place a Back -to-back TRS order to CSICM on the terms of the ISDA
|
||
Agreement. In order to hedge its exposure under the Back -to-back TRS, CSICM participates in the
|
||
Company’s IPO and subscribes the Offer Shares through placing order with CLSA during the International
|
||
Offering.
|
||
|
||
The CSICM Ultimate Client for purpose of this placing subscription include the following investment fund
|
||
managed by Shanghai Panjing Investment Management Center (Limited Partnership) (上海盘京投资管理
|
||
中心（有限合伙）):
|
||
|
||
(a) Shanghai Panjing Investment Management Center (Limited Partnership) (上海盘京投资管理中心
|
||
（有限合伙）), whose ultimate beneficial owner holding 30% interests or more therein is Zhuang
|
||
Tao (庄涛).
|
||
|
||
To the best knowledge of CSICM after making all reasonable enquiries, the CSICM Ultimate Client is an
|
||
independent third party of CSICM and CLSA, the companies which are members of the same group of
|
||
companies as CLSA and the Company.
|
||
|
||
Pursuant to the terms of the contracts of the Back -to-back TRS and the Client TRS, during the tenor of the
|
||
Back-to-back TRS and the Client TRS, all economic returns of the Offer Shares will be passed to the CSICM
|
||
Ultimate Client through the Back-to-back TRS and the Client TRS and all economic loss shall be borne by
|
||
the CSICM Ultimate Client. CSICM will not take any economic return or bear any economic loss in relation
|
||
to the Offer Shares.
|
||
|
||
Investment in the Back-to-back TRS and the Client TRS is similar to the investment in a qualified domestic
|
||
institutional investor fund (“QDII”) in the way that the CSICM Ultimate Client would reap all the economic
|
||
benefits of the underlying Offer Shares, except that a QDII fund would pass through the exchange rate
|
||
exposure on both the notional value of the investment and the profit and loss of the investment. In contrast,
|
||
the profit and loss of the Back-to-back TRS and the Client TRS factor into account the fluctuation in RMB
|
||
exchange rate upon termination of the Client TRS by converting the profit and loss using the current
|
||
exchange rate at the time of termination. As such, the CSICM Ultimate Client would bear the exchange rate
|
||
exposure of the profit and loss on settlement date.
|
||
|
||
The CSICM Ultimate Client may exercise an early termination right to terminate the Client TRS at any time
|
||
from the issue date of the Client TRS which should be on or after t he date on which the Offer Shares are
|
||
listed on the Stock Exchange. Upon the termination upon maturity or early termination of the Client TRS
|
||
by the CSICM Ultimate Client, CSICM will dispose the Offer Shares on the secondary market and the
|
||
CSICM Ultimate Client will receive a final settlement amount of the Back-to-back TRS which should have
|
||
taken into account all the economic returns or economic loss in relation to the Offer Shares. If upon the
|
||
maturity of the Client TRS, the CSICM Ultimate Client intends to extend the investment period, subject to
|
||
|
||
|
||
--- page 26 ---
|
||
No.
|
||
Connected
|
||
Client
|
||
Connected
|
||
Distributor
|
||
Relationship
|
||
with the
|
||
Connected
|
||
Distributor
|
||
Whether the
|
||
connected client
|
||
will hold
|
||
beneficial
|
||
interests of Offer
|
||
Shares on a
|
||
nondiscretionary
|
||
or discretionary
|
||
basis for
|
||
independent
|
||
third parties
|
||
Number
|
||
of Offer
|
||
Shares to
|
||
be
|
||
allocated
|
||
to the
|
||
connected
|
||
client
|
||
Appropriate
|
||
percentage
|
||
of total
|
||
number of
|
||
Offer
|
||
Shares
|
||
Approximate
|
||
percentage
|
||
of total
|
||
issued share
|
||
capital
|
||
immediately
|
||
following the
|
||
completion
|
||
of Global
|
||
Offering
|
||
further agreement between CSICM and the CSICM Ultimate Client, the term of the Client TRS could be
|
||
extended by way of a new issuance or a tenor extension. Accordingly, CSICM will extend the term of the
|
||
Back-to-back TRS by way of a new issuance or a tenor extension.
|
||
|
||
It is proposed that CSICM will hold the legal title and the voting right of the Offer Shares by itself, and pass
|
||
through the economic exposure to the CSICM Ultimate Client, which places a Client TRS order through its
|
||
asset manager with CITIC Securities in connection with the IPO of the Company. Due to its internal policy,
|
||
CSICM will not exercise the voting right of the Offer Shares during the tenor of the Back-to-back TRS.
|
||
|
||
During the life of the Client TRS and Back -to-back TRS, CSICM may continue to hold the Offer Shares in
|
||
its custodian account, or to hold some or all of the Offer Shares in a prime brokerage a ccount for stock
|
||
borrowing purposes.
|
||
|
||
As permitted under the contractual arrangement with the CSICM Ultimate Client, CSICM will lend out its
|
||
holding of underlying Offer Shares in the form of stock borrowing loans consistent with market practice to
|
||
lower its finance costs, provided that CSICM has the ability to call back the Offer Shares on loan at any
|
||
time in order to satisfy its obligations under the Back -to-back TRS to ensure the economic interests to be
|
||
passed to the CSICM Ultimate Client under the Client TRS will remain unchanged.
|
||
|
||
2. China AMC HK will hold the Offer Shares in its capacity as discretionary fund manager managing assets on
|
||
behalf of its underlying clients. To the best of China AMC HK’s knowledge after due enquiry, each underlying
|
||
clients of China AMC HK is an independent third party of China AMC HK, CLSA and the companies which
|
||
are members of the same group of CLSA.
|
||
|
||
3. CMBI SG will hold the Offer Shares in its capacity as discretionary investment manager managing assets on
|
||
behalf of its underlyi ng client. To the best of CMBI SG’s knowledge after due enquiry, the underlying client
|
||
of CMBI SG is an independent third party of CMBI SG, the CMBI Connected Distributors and the companies
|
||
which are members of the same group of the CMBI Connected Distributors.
|
||
|
||
4. Bosera AM will hold the Offer Shares in its capacity as discretionary fund manager managing assets on behalf
|
||
of its underlying clients. To the best of Bosera AM’s knowledge after due enquiry, each underlying clients of
|
||
Bosera AM is an independent third party of Bosera AM, the CMBI Connected Distributors and the companies
|
||
which are members of the same group of the CMBI Connected Distributors.
|
||
|
||
|
||
DISCLAIMERS
|
||
|
||
Hong Kong Exchanges and Clearing Limited, The Stock Exchange of Hong Kong Limited (the
|
||
“Stock Exchange ”) and Hong Kong Securities Clearing Company Limited (“HKSCC”) take
|
||
no responsibility for the contents of this announcement, make no representation as to its
|
||
accuracy or completeness and expressly disclaim any liability whatsoever for any loss
|
||
howsoever arising from or in reliance upon the whole or any part of the contents of this
|
||
announcement.
|
||
This announcement is not for release, publication, distribution, directly or indirectly, in or into
|
||
the United States (including its territories and possessions, any state of the United States and
|
||
|
||
|
||
--- page 27 ---
|
||
the District of Columbia). This announcement does not const itute or form a part of any offer or
|
||
solicitation to purchase or subscribe for securities in the United States. The securities
|
||
mentioned herein have not been, and will not be, registered under the United States Securities
|
||
Act of 1933, as amended (the “ U.S. Securities Act ”). The securities may not be offered or sold
|
||
in the United States except pursuant to an exemption from the registration requirements of the
|
||
U.S. Securities Act and in compliance with any applicable state securities laws, or outside the
|
||
United States unless in compliance with Regulation S under the U.S. Securities Act. There will
|
||
be no public offer of securities in the United States.
|
||
The Offer Shares are being offered and sold solely outside the United States in offshore transactions
|
||
in reliance on Regulation S under the U.S. Securities Act.
|
||
This announcement is for information purposes only and does not constitute an invitation or
|
||
offer to acquire, purchase or subscribe for securities. This announcement is not a prospectus.
|
||
Potential investors should read the Prospectus dated September 26, 2025 issued by CF
|
||
PharmTech, Inc. for detailed information about the Global Offering described below before
|
||
deciding whether or not to invest in the Shares thereby being offered .
|
||
*Potential investors of the Offer Shares should note that the Joint Representatives (for
|
||
themselves and on behalf of the Hong Kong Underwriters) shall be entitled to terminate their
|
||
obligations under the Hong Kong Underwriting Agreement with immediate effect upon the
|
||
occurrence of any of the events set out in the paragraph headed “Underwriting – Underwriting
|
||
Arrangements and Expenses – Hong Kong Public Offering – Hong Kong Underwriting
|
||
Agreement – Grounds for Termination ” in the Prospectus at any time prior to 8:00 a.m. (Hong
|
||
Kong time) on the Listing Date (which is currently expected to be on October 8, 2025).
|
||
|
||
PUBLIC FLOAT AND FREE FLOAT
|
||
Upon Listing, 230,935,230 H Shares, equivalent to 56.1% of the total number of issued Shares of the
|
||
Company, will be counted towards the public float. Therefore, the number of H Shares held in public
|
||
hands is higher than the prescribed percentage of H Shares required to be held in public hands under
|
||
Rule 19A.13A(1) of the Listing Rules, representing 24.7% of H Shares to be held in public hands with
|
||
the expected market value of HK$1.5 billion at the time of Listing, based on the Offer Price of
|
||
HK$14.75 per H Share.
|
||
Based on the Offer Price of HK$14.75 per Share, the Company satisfies t he free float requirement
|
||
under Rule 19A.13C(1) of the Listing Rules.
|
||
The Directors confirm that, immediately following the completion of the Global Offering, (i) no placee
|
||
will, individually, be placed more than 10% of the enlarged issued share capital of the Company
|
||
immediately after the Global Offering; (ii) there will not be any new substantial Shareholder
|
||
immediately after the Global Offering; (iii) the three largest public shareholders of the Company do
|
||
not hold more than 50% of the H Shares in public hands at the time of the Listing in compliance with
|
||
Rules 8.08(3) and 8.24 of the Listing Rules; and (iv) there will be at least 300 Shareholders at the time
|
||
of the Listing in compliance with Rule 8.08(2) of the Listing Rules.
|
||
COMMENCEMENT OF DEALINGS
|
||
The H Share certificates will only become valid evidence of title at 8:00 a.m. on Wednesday, October
|
||
8, 2025 (Hong Kong time), provided that the Global Offering has become unconditional and the right
|
||
of termination described in the section headed “Underwritin g – Underwriting Arrangements and
|
||
Expenses – Hong Kong Public Offering – Grounds for Termination” in the Prospectus has not been
|
||
|
||
|
||
--- page 28 ---
|
||
exercised. Investors who trade the H Shares on the basis of publicly available allocation details prior
|
||
to the receipt of H Sha re certificates or prior to the H Share certificates becoming valid evidence of
|
||
title do so entirely at their own risk.
|
||
Assuming that the Global Offering becomes unconditional at or before 8:00 a.m. on Wednesday,
|
||
October 8, 2025 (Hong Kong time), it is expected that dealings in the H Shares on the Stock Exchange
|
||
will commence at 9:00 a.m. on Wednesday, October 8, 2025 (Hong Kong time). The H Shares will be
|
||
traded in board lots of 500 H Shares each, and the stock code of the H Shares will be 2652.
|
||
|
||
By order of the Board
|
||
CF PharmTech, Inc.
|
||
長風藥業股份有限公司
|
||
Dr. LIANG Bill Wenqing
|
||
Chairperson, Executive Director and Chief Executive Officer
|
||
|
||
Hong Kong, October 6, 2025
|
||
As at the date of this announcement, the board of directors (“ Board”) comprises of Dr. LIANG Bill
|
||
Wenqing as the chairperson of the Board, executive Director and Chief Executive Officer, Dr. LI LI
|
||
BOVET, Dr. LI Qi and Ms. ZHU Yuyu as executive Directors, Mr. CHEN Penghui, Mr. CAI Lei and
|
||
Dr. YI Hua as non -executive Directors, and Dr. JIN Jian, Ms. WANG Lijuan, Mr. WEI Shirong and
|
||
Mr. IP Wang Hoi as independent non-executive Directors.
|